共 33 条
- [4] The benefits of peritoneal dialysis (PD) solution with low-glucose degradation product in residual renal function and dialysis adequacy in PD patients: A meta-analysis INVESTIGACION CLINICA, 2022, 63 (03): : 283 - 303
- [7] ASSOCIATIONS BETWEEN PERITONEAL GLUCOSE EXPOSURE, GLUCOSE DEGRADATION PRODUCT EXPOSURE, AND PERITONEAL MEMBRANE TRANSPORT CHARACTERISTICS IN PERITONEAL DIALYSIS PATIENTS: SECONDARY ANALYSIS OF THE balANZ TRIAL PERITONEAL DIALYSIS INTERNATIONAL, 2018, 38 (05): : 349 - 355
- [9] NEUTRAL SOLUTION LOW IN GLUCOSE DEGRADATION PRODUCTS IS ASSOCIATED WITH LESS PERITONEAL FIBROSIS AND VASCULAR SCLEROSIS IN PATIENTS RECEIVING PERITONEAL DIALYSIS PERITONEAL DIALYSIS INTERNATIONAL, 2013, 33 (03): : 242 - 251
- [10] Efficacy and safety of febuxostat in peritoneal dialysis patients with hyperuricemia: a pilot study with one year follow-up INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (01): : 192 - 200